|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 26, 2016 ) Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global Size and Share Published in 2015-08-25 Available for US$ 1290 at Researchmoz.us
Description
Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have captured maximum market share of the Hepatitis C market. Gilead currently dominates the multi-billion dollar Hepatitis C market, but AbbVie has been trying to increase its market share since U.S. regulators approved the marketing of its Viekira Pak. Drug makers are already focusing on introducing new drugs in the market as several drugs are standing in the pipeline. Hepatitis C Drugs is anticipated to be a rosy market for future period.
This is 3rd edition report on Hepatitis C Drugs Industry. Report titled “Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Hepatitis sector. This 87 page report with 18 Figures and 1 Table studies the Hepatitis C Drug Market Landscape.
Hepatitis C Drugs Market & Forecast (Chapter 2)
Hepatitis C Approved Drugs Sales & Forecast (Chapter 3)
Hepatitis C – Pipeline Drugs Sales & Forecast (Chapter 4)
Hepatitis C Deals & Acquisitions (Chapter 5)
Hepatitis C – Company Wise Clinical Trial Analysis (Chapter 6)
Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=423184
Hepatitis C – Approved Drugs Sales & Forecast (To 2020) (Chapter No. 3)
Pegasys
Pegintron
Incivek
Victrelis
Olysio
Sovaldi/Harvoni
HCV Franchise
Viekira Pak
Hepatitis C – Pipeline Drugs Sales Forecast (To 2020) (Chapter No. 4)
Drug A (Merck & Co. Inc.)
Drug B (Merck & Co. Inc.)
Drug C (Bristol-Myers Squibb)
Hepatitis C – Company Wise Clinical Trial Analysis (Chapter No.5)
AbbVie
Bristol-Myers Squibb (BMS)
Gilead Sciences
Merck & Co. Inc.
Tibotec/Janssen Therapeutics
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=423184
Table of Content
1. Executive Summary
2. Hepatitis C Drugs – Market & Forecast
3. Hepatitis C – Approved Drugs Sales & Forecast
3.1 Pegasys Sales & Forecast
3.2 Pegintron Sales & Forecast
3.3 Incivek Sales
3.4 Victrelis Sales & Forecast
3.5 Olysio Sales & Forecast
3.6 Sovaldi / Harvoni Sales & Forecast
3.7 HCV Franchise Sales & Forecast
3.8 Viekira Pak Sales & Forecast
Browse All Pharmaceutical Market Research Reports at http://www.researchmoz.us/pharmaceutical-market-reports-38.html
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.
Contact Us:
ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us <||>rnhttp://www.researchmoz.us/
For More Report Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
